Ivermectin synergizes sorafenib in hepatocellular carcinoma via targeting multiple oncogenic pathways

Abstract Advanced hepatocellular carcinoma (HCC) results in generally poor clinical outcomes and necessitates better therapeutic strategies. Ivermectin, which is an existing anti‐parasitic drug, has been recently identified as a novel anti‐cancer drug. In line with previous efforts, this work demons...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Haofeng Lu (Autor), Lin Zhou (Autor), Hongping Zuo (Autor), Wenjin Le (Autor), Jianfei Hu (Autor), Tiequan Zhang (Autor), Mi Li (Autor), Yufeng Yuan (Autor)
Format: Knjiga
Izdano: Wiley, 2022-06-01T00:00:00Z.
Teme:
Online pristup:Connect to this object online.
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

Connect to this object online.

3rd Floor Main Library

Detalji primjeraka od 3rd Floor Main Library
Signatura: A1234.567
Primjerak 1 Dostupno